Delivery Order SPE2DE24DA010-SPE2D625F5EE0

Award Date 7/3/25
Potential Completion Date 7/9/25
Potential Value $5.7K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
This federal contract award to Abbott Laboratories Inc., a global healthcare company, was issued by the Defense Logistics Agency (DLA) for the delivery of cardiovascular medical devices and related services. The $7,941.84 fixed-price contract with economic price adjustment has a completion date of June 20, 2025. Abbott Laboratories, through its Abbott Vascular Inc. division, has established itself as a critical supplier of advanced cardiovascular technologies to federal healthcare systems,...
This federal contract award, valued at $24,350.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc.'s Abbott Vascular Inc. division. The award is a fixed-price delivery order contract for the delivery of cardiovascular medical devices and related services, such as electrophysiology catheters, heart valve prosthetics, surgical implants, cardiac mapping systems, and neuromodulation devices. The contract has an ultimate completion...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order for fixed-price cardiovascular medical devices with economic price adjustment, with a completion date of March 18, 2025. The award was made under an Indefinite Delivery Contract (IDC), likely an existing Blanket Purchase Agreement (BPA) between Abbott Laboratories and the Department of...
This federal contract award is for the delivery of cardiovascular medical devices and related services to the Department of Veterans Affairs (VA) and Defense Logistics Agency (DLA). The prime contractor is Abbott Laboratories Inc., through its Abbott Vascular Inc. division, a major global manufacturer of medical devices. The $2,373 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not have a set-aside designation, indicating full and open...
This federal contract award, valued at $11,750.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of March 3, 2025. The award does not have a set-aside designation, indicating full and open competition. The contract provides for the delivery of...
This federal contract award is for the delivery of cardiovascular medical devices and related services to the Department of Veterans Affairs (VA) and Defense Health Agency. The prime contractor is Abbott Laboratories Inc., a large multinational pharmaceutical and medical device manufacturer, through its Abbott Vascular Inc. division. The contract has a ceiling value of $25,995.85 and an ultimate completion date of February 6, 2025. It is a fixed-price delivery order contract with economic...
This federal contract award, valued at $26,275.85, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer. The contract is a fixed-price delivery order with an economic price adjustment clause, tasking Abbott Vascular Inc., a division of Abbott Laboratories, to provide a range of cardiovascular medical devices and related services to federal healthcare systems, particularly the...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company that specializes in medical devices, diagnostics, and pharmaceuticals. The award is a delivery order contract with a fixed price and economic price adjustment mechanism. The contract has no set-aside designation, indicating full and open competition. The contract requires Abbott Laboratories Inc., through its Abbott Vascular Inc. division,...
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F5EE0
    Delivery Order

This federal contract award was made by the Medical Supply Chain, a division of the Defense agency, to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $5,695.00 fixed-price with economic price adjustment delivery order contract is for the provision of cardiovascular medical devices and related services to support federal healthcare systems, particularly the Department of Veterans Affairs (VA) and the Defense Logistics Agency (DLA).

The contract has an ultimate completion date of July 9, 2025 and was awarded on July 3, 2025 without any set-aside designation, indicating full and open competition. Abbott Laboratories Inc. is a global healthcare company that specializes in medical devices, diagnostic equipment, and pharmaceuticals. The company has secured numerous federal contract awards and Indefinite Delivery Vehicles (IDVs) to supply a wide range of cardiovascular technologies, medical equipment, and integrated technology solutions to the VA and DLA.

Generated 10/2/25, 11:13 AM